EcoDrugPlus

Carbonic Anhydrase 14

Ensembl ID : ENSSLDG00000015501
Gene Symbol: CA14
3 Cross references
210 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSSLDG00000019566
Gene Symbol: CA4
3 Cross references
212 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSSLDG00000009705
Gene Symbol: LOC111650669
3 Cross references
196 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSSLDG00000016273
Gene Symbol: LOC111647478
3 Cross references
79 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSSLDG00000014308
Gene Symbol: CA5A
3 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSSLDG00000001669
Gene Symbol: CA6
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSSLDG00000000431
Gene Symbol: CA7
3 Cross references
221 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSSLDG00000024946
Gene Symbol: CSNK1E
3 Cross references
211 Possible Orthologues:

Casein Kinase I-Like

Ensembl ID : ENSSLDG00000008913
Gene Symbol: LOC111646153
3 Cross references
196 Possible Orthologues:

Caspase 9

Ensembl ID : ENSSLDG00000019012
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol O-Methyltransferase-Like

Ensembl ID : ENSSLDG00000012626
Gene Symbol: LOC111649264
3 Cross references
213 Possible Orthologues:

Catechol O-Methyltransferase-Like

Ensembl ID : ENSSLDG00000009969
Gene Symbol: LOC111653193
3 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).